Summary
AmerisourceBergen Corporation (COR) reported solid financial results for the quarter ended March 31, 2006, with total revenue increasing 15% year-over-year to $15.2 billion. This growth was primarily driven by a 15% increase in the Pharmaceutical Distribution segment's operating revenue, which reached $13.9 billion. The company demonstrated strong operational execution, with net income rising 30% to $129 million, and diluted earnings per share increasing 36% to $0.61. The company also made significant progress in its strategic initiatives, including acquisitions in Canada and the UK, and continued efforts to transition its distribution model to a fee-for-service basis, which is expected to improve earnings predictability. Key financial developments include a substantial increase in cash and cash equivalents to over $1 billion, reflecting strong operating cash flows. The company also repurchased a significant amount of its common stock under its share repurchase program. While the Pharmaceutical Distribution segment showed robust growth, the PharMerica segment experienced a decline in operating income due to changes in Medicare Part D reimbursement. Management remains optimistic about future growth, projecting a revenue increase of 10-12% for fiscal year 2006.
Key Highlights
- 1Total revenue increased by 15% to $15.2 billion for the quarter ended March 31, 2006.
- 2Net income grew by 30% to $129 million, with diluted EPS rising 36% to $0.61.
- 3Pharmaceutical Distribution segment revenue increased 15% to $13.9 billion, driven by growth in both institutional and retail customer sales.
- 4The company acquired four businesses in Canada and the UK during the six months ended March 31, 2006, expanding its international presence.
- 5Cash and cash equivalents increased significantly to $1.05 billion at quarter-end.
- 6The company continued its share repurchase program, buying back 1.0 million shares for $43.3 million during the quarter.